15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 7 firms covering Cryoport Inc, 7 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets range widely, $12.00 to $25.00 (about 2.1x), a sign of real disagreement on valuation. The average target of $16.79 sits 11% above the current $15.17. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.16 next quarter toward $-0.62 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS7 ratings
Strong Buy
Strong Buy00%
Buy7100%
Hold00%
Sell00%
Strong Sell00%
Based on 7 analysts giving stock ratings to Cryoport Inc.
As of Jul, 7 of 7 firms rate CYRX a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CYRX EPS & revenue forecast
EPS · NEXT QUARTER
$-0.16
Range $-0.18 – $-0.15 · 3 analysts · +23% YoY
Next period, 3 analysts expect Cryoport Inc to earn $-0.16 a share (range $-0.18 – $-0.15), versus $-0.13 a year earlier. Full-year consensus is $-0.73, growing to $-0.62 the year after.
REVENUE · NEXT QUARTER
$48.4M
Range $48.0M – $48.9M · 3 analysts · +9% YoY
Revenue is expected to reach $48.4M (range $48.0M – $48.9M), +9.4% year-over-year. Full-year consensus is $194.4M, rising to $213.1M next year.
Top analysts covering Cryoport Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CYRX.
#1
David Saxon
Needham · Rank #264
Buy
$15.00-1.1% to target
Overall win rate
34%
+ Follow
#2
Richard Baldry
Roth MKM · Rank #294
Buy
$15.00-1.1% to target
Overall win rate
30%
+ Follow
#3
Paul Knight
Keybanc · Rank #296
Buy
$17.00+12.1% to target
Overall win rate
32%
+ Follow
#4
David Larsen
BTIG
Buy
$25.00+64.8% to target
Coverage
—
+ Follow
#5
Subbu Nambi
Guggenheim
Buy
$12.00-20.9% to target
Coverage
—
+ Follow
CYRX stock forecast FAQ
What is CYRX's average 12-month price target?+
The 7 analysts with a live target average $16.79 for Cryoport Inc over the next 12 months, ranging from a $25.00 high to a $12.00 low.
Is CYRX stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 7 analyst ratings, 7 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CYRX?+
The Street-high target is $25.00 (BTIG), and the Street-low is $12.00 (Guggenheim). The average of all 7 active targets is $16.79.
How many Wall Street analysts cover CYRX?+
7 analysts have an active rating on Cryoport Inc, and 7 firms carry a live 12-month price target.
Who is the most accurate analyst covering CYRX?+
Among analysts who currently cover CYRX, David Saxon of Needham has the strongest overall Quantellect track record (Rank #264). Their current call is Buy with a $15.00 target.
What is Cryoport Inc's projected EPS for next quarter?+
The consensus estimate is $-0.16 per share (range $-0.18 – $-0.15) across 3 analysts. Full-year EPS is projected at $-0.73, rising to $-0.62 the following year.
How much revenue is Cryoport Inc expected to report next quarter?+
Consensus revenue is $48.4M (range $48.0M – $48.9M). Full-year revenue is projected at $194.4M, growing to $213.1M next year.
Have analysts been upgrading or downgrading CYRX lately?+
As of Jul, 7 of 7 firms rate CYRX a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CYRX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
